摘要
宏基因组学的不断发展,揭示了微生物菌群在许多疾病的发生和发展中发挥着重要作用。国内外大量研究表明位于鼻咽部、口咽部和(或)肺部的菌群在慢性阻塞性肺疾病(COPD)、哮喘、囊性纤维化(CF)、支气管扩张、上呼吸道感染等呼吸道疾病发生了定性和/或定量的改变,并影响机体的免疫、代谢和神经调节等过程。这些研究成果或将为呼吸道疾病的诊断、治疗、病情监测及预后判断提供新的策略。
The development of metagenomics revealed a novel role of microorganism in lots of diseases Emerging researches at home and abroad illustrated that microbiome changes from nasopharynx, oropharynx and/or lung in quality and/or quantity exist in many respiratory diseases including chronic obstructive pulmonary disease, asthma, cystic fibrosis, pneumonia as well as upper respiratory infection, which play an important role in immune system, metabolism and neuroregulation. These research results may provide us new strategy for the diagnosis, therapy, surveillance and prognosis of respiratory diseases,
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2016年第4期322-325,共4页
Chinese Journal of Laboratory Medicine
关键词
微生物学
呼吸道疾病
Microbiology
Respiratory tract diseases